Revenue Breakdown
Composition ()
No data
Revenue Streams
Agilent Technologies Inc (A) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Non-instrumentation and other, accounting for 63.4% of total sales, equivalent to $1.14B. Another important revenue stream is Instrumentation. Understanding this composition is critical for investors evaluating how A navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Agilent Technologies Inc maintains a gross margin of 54.11%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 22.18%, while the net margin is 18.47%. These profitability ratios, combined with a Return on Equity (ROE) of 21.33%, provide a clear picture of how effectively A converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, A competes directly with industry leaders such as WAT and BDX. With a market capitalization of $35.89B, it holds a significant position in the sector. When comparing efficiency, A's gross margin of 54.11% stands against WAT's 34.41% and BDX's 46.58%. Such benchmarking helps identify whether Agilent Technologies Inc is trading at a premium or discount relative to its financial performance.
